SYMTUZA

Identification of Symtuza

No description

Google image searchProduct monograph

Active ingredients

darunavir (darunavir ethanolate), 800 MG

cobicistat, 150 MG

emtricitabine, 200 MG

tenofovir alafenamide (tenofovir alafenamide hemifumarate), 10 MG

DIN: 02473720

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 25-APR-2018

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR22 — EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT (ATC/DDD)

Reference brand drug: Symtuza

Pharmaceutical standard: USP

External Links for Symtuza

Search on Google

• Symtuza side effects
• Symtuza dosage
• darunavir side effects
• darunavir dosage
• cobicistat side effects
• cobicistat dosage
• emtricitabine side effects
• emtricitabine dosage
• tenofovir alafenamide side effects
• tenofovir alafenamide dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find symtuza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.